|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
8
|
|
pubmed:dateCreated |
2009-4-8
|
|
pubmed:abstractText |
Idiopathic pulmonary fibrosis (IPF) is a devastating lung disease with a poor prognosis. There is great effort to find predictors of outcome. Conclusive data for any serum biomarker are lacking. We have recently documented that serum CCL18 concentrations correlate with the course of pulmonary function data in patients with pulmonary fibrosis of various causes.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1535-4970
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
15
|
|
pubmed:volume |
179
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
717-23
|
|
pubmed:meshHeading |
pubmed-meshheading:19179488-Aged,
pubmed-meshheading:19179488-Biological Markers,
pubmed-meshheading:19179488-Chemokines, CC,
pubmed-meshheading:19179488-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:19179488-Female,
pubmed-meshheading:19179488-Humans,
pubmed-meshheading:19179488-Idiopathic Pulmonary Fibrosis,
pubmed-meshheading:19179488-Male,
pubmed-meshheading:19179488-Middle Aged,
pubmed-meshheading:19179488-Prognosis,
pubmed-meshheading:19179488-Prospective Studies,
pubmed-meshheading:19179488-Respiratory Function Tests,
pubmed-meshheading:19179488-Survival Analysis
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Serum CC-chemokine ligand 18 concentration predicts outcome in idiopathic pulmonary fibrosis.
|
|
pubmed:affiliation |
Department of Pneumology, University Freiburg, Germany. antje.prasse@uniklinik-freiburg.de
|
|
pubmed:publicationType |
Journal Article
|
